A specific vascular endothelial growth factor receptor tyrosine kinase inhibitor enhances the antiproliferative effect of trastuzumab in human epidermal growth factor receptor 2 overexpressing breast cancer cell lines. Discussion
Saved in:
Published in | The American journal of surgery Vol. 197; no. 3; pp. 331 - 336 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
New York, NY
Elsevier
2009
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
ISSN: | 0002-9610 1879-1883 |
---|